Navigation Links
BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Date:8/19/2007

Significant Improvement in Number and Viability of Stem Cells Derived from

Cord Blood Enabled by BioLife's Patented Preservation Media

BOTHELL, Wash., Aug. 17 /PRNewswire-FirstCall/ -- BioLife Solutions Inc. (OTC Bulletin Board: BLFS), a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced an agreement as the exclusive supplier of preservation media to the New England Cryogenic Center, Inc. (NECC), one of the world's largest providers of cryogenically preserved human cells and tissues.

The five year agreement includes volume based pricing and an exclusive commitment from NECC to purchase all of its demand for cord blood preservation media from BioLife.

New England Cord Blood Bank Chief Executive John Rizza remarked: "We continually strive to improve our cord blood preservation protocols and results, and we've seen significant improvement in post-thaw cell recovery and viability with BioLife's CryoStor, compared to our prior in-house media formulations. In addition, pre-formulated and sterile CryoStor eliminates our labor cost of mixing preservation media in our lab. CryoStor is also serum-free and protein-free, so this resolved an albumin supply issue we faced. Based on our early experience, we're quite interested in evaluating BioLife's preservation media for use by our affiliated sperm bank and for other emerging stem cell applications."

BioLife Chief Executive Mike Rice commented: "The New England Cryogenic Center and their affiliates around the world are on the leading edge of preservation science, so we're very pleased to become their exclusive supplier and count them as a key customer and research partner in developing new applications for CryoStor and other our preservation media products."

According to an August 2006 research report published by Jain PharmaBiotech, the total value of cell-based markets was $27 billion in 2005 and is expected to grow to $96 billion in 2015, as more than 300 companies are engaged in developing cell-based alternatives to medical devices and drugs to treat and possibly cure numerous acute and chronic diseases.

PA Consulting Group, a global consulting firm with expertise in life sciences and healthcare, estimates the worldwide market for media to preserve cells, tissues, and organs for research and clinical applications will grow from $200 million in 2007 to more than $325 million by 2011.

About New England Cryogenic Center

New England Cryogenic Center, Inc. is the world's premier cryogenic storage facility for the long-term storage of human cells and tissues, offering personal service, cutting-edge technology, and the most secure facilities available. The Company's unmatched experience -- in cryogenics since 1982 and cord blood banking for the last decade - delivers the expertise and quality families desire at an affordable price. For more information, please visit http://www.cordbloodbank.com

About BioLife Solutions

BioLife Solutions develops, manufactures and markets patented hypothermic storage and cryopreservation solutions for cells, tissues, and organs. The Company's proprietary HypoThermosol(R) and CryoStor(TM) platform of solutions are marketed to academic and commercial organizations involved in cell therapy, tissue engineering, cord blood banking, drug discovery, and toxicology testing. BioLife's products are serum-free and protein-free, fully defined, and are formulated to reduce or prevent preservation-induced, delayed-onset cell damage and death. BioLife's enabling technology provides academic and clinical researchers significant improvements in post-thaw cell, tissue, and organ viability and function. For more information please visit http://www.biolifesolutions.com.

This news release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements include any statements that relate to the intent, belief, plans or expectations of the Company or its management, or that are not a statement of historical fact. Any forward-looking statements in this news release are based on current expectations and beliefs and are subject to numerous risks and uncertainties that could cause actual results to differ materially. Some of the specific factors that could cause BioLife Solutions' actual results to differ materially are discussed in the Company's recent filings with the Securities and Exchange Commission. BioLife Solutions disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

Media Relations: Investor Relations:

Len Hall Matt Clawson

Allen & Caron Inc. Allen & Caron Inc.

(949) 474-4300 (949) 474-4300

len@allencaron.com matt@allencaron.com


'/>"/>
SOURCE BioLife Solutions Inc.

Copyright©2007 PR Newswire.

Related biology technology :

1. Sample Preparation Solutions for Cellular Protein Fractionation Poster, Rev A
2. Long-Term Instrument Control and Connectivity Solutions
3. PathCheck Applied to Measurement of Protein Solutions in the SpectraMax Plus Microplate Spectrophotometer (MaxLine Application Note #26)
4. Verifying Multichannel Pipettor Performance with Standard Dispense Solutions in the SpectraMax Plus (MaxLine Application Note #28)
5. Software company enters health space with RFID solutions on hold
6. eCare Solutions, UW Milwaukee to study health web sites
7. Tech Digest - RedPrairie; Wind Lake Solutions
8. Cooper Lighting picks RedPrairie solutions
9. Ten resolutions that could produce a happy new (tech) year
10. Inacom named Microsofts favorite learning solutions partner of the year
11. Blue Cross BlueShield of South Carolina implements Esker solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission ... hardware projects are designed, built and brought to market. , The Design Lab ...
(Date:6/23/2016)... ... 23, 2016 , ... In a new case report published today in STEM ... who developed lymphedema after being treated for breast cancer benefitted from an injection of ... dealing with this debilitating, frequent side effect of cancer treatment. , Lymphedema ...
(Date:6/23/2016)... BEACH, Calif. , June 23, 2016  Blueprint ... new biological discoveries to the medical community, has closed ... co-founder Matthew Nunez . "We have ... us with the capital we need to meet our ... will essentially provide us the runway to complete validation ...
Breaking Biology Technology:
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/31/2016)... 31, 2016  Genomics firm Nabsys has completed a ... Barrett Bready , M.D., who returned to the company ... technical leadership team, including Chief Technology Officer, John ... Steve Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
Breaking Biology News(10 mins):